Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma

Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM

NCT02436733 ·Status: UNKNOWN ·Phase: PHASE2

Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer

NCT06467786 ·Status: RECRUITING ·Phase: PHASE4

Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases

NCT01114958 ·Status: COMPLETED ·Phase: PHASE1

Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients

NCT02899299 ·Status: COMPLETED ·Phase: PHASE3

A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma

NCT02707666 ·Status: TERMINATED ·Phase: PHASE1

Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer

NCT06016179 ·Status: RECRUITING ·Phase: PHASE1

Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma

NCT02668393 ·Status: COMPLETED ·Phase: PHASE1

Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.

NCT03213301 ·Status: COMPLETED ·Phase: PHASE2

Inhalation SLIT Cisplatin (Liposomal) for the Treatment of Osteosarcoma Metastatic to the Lung

NCT00102531 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Drug Sensitivity Correlation Between Patient-Derived Organoid Model and Clinical Response in NSCLC Patients

NCT03453307 ·Status: UNKNOWN

Clinical Trial of Tumor Cell-derived Microparticles Packaging Chemotherapeutic Drugs to Treat Malignant Pleural Effusion

NCT02657460 ·Status: UNKNOWN ·Phase: PHASE2

Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer

NCT00003496 ·Status: TERMINATED ·Phase: PHASE2

PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery

NCT00365053 ·Status: COMPLETED ·Phase: PHASE2

Photo-induction as a Means to Improve Cisplatin Delivery to Pleural Malignancies

NCT02702700 ·Status: TERMINATED ·Phase: PHASE1

An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer

NCT06693336 ·Status: RECRUITING ·Phase: PHASE2

Long-term Outcomes Among Patients With Programmed Death-ligand 1 <1% Metastatic Non-small Cell Lung Cancer Treated With First-line Nivolumab + Ipilimumab + 2 Cycles of Chemotherapy

NCT07024862 ·Status: ACTIVE_NOT_RECRUITING

Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC

NCT02504489 ·Status: COMPLETED ·Phase: PHASE3

Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer

NCT05244239 ·Status: RECRUITING ·Phase: PHASE1

HPPH and PDT for Pleural Malignancy

NCT01673074 ·Status: COMPLETED ·Phase: PHASE1

MPDL3280A With Chemoradiation for Lung Cancer

NCT02525757 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of LY3023414 and Necitumumab in Squamous Lung Cancer

NCT02443337 ·Status: TERMINATED ·Phase: PHASE2

Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer

NCT02016209 ·Status: UNKNOWN ·Phase: PHASE2

Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs

NCT00020124 ·Status: COMPLETED ·Phase: PHASE1

Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients

NCT04696939 ·Status: UNKNOWN ·Phase: PHASE2

Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

NCT00003497 ·Status: TERMINATED ·Phase: PHASE2